Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells

Abstract

Akt, when activated by IGF/insulin, can phosphorylate forkhead transcription factors. We undertook this study to determine whether epidermal growth factor (EGF) treatment could produce a signaling cascade resulting in phosphorylation of the forkhead transcription factor FKHR in a breast cancer cell line, MDA-MB-231. After establishing ErbB1, cbl, PI3 kinase and Akt were activated in EGF treated MDA-MB-231, we determined by immunoblot with FKHR antiserum that the electrophoretic mobility of FKHR was retarded after EGF treatment. This mobility retardation was reversible by treatment with alkaline phosphatase, and immunoblot with phospho-Ser256 FKHR antibody further confirmed phosphorylation on an Akt consensus site after EGF treatment. EGF stimulated FKHR phosphorylation was blocked by the PI3 kinase inhibitor LY294002, and the ErbB1 inhibitor AG1478. FKHR immunoblotting after purification of nuclear and cytoplasmic proteins showed that EGF induced a simultaneous increase of FKHR in the cytoplasm and decrease in the nucleus. This finding was confirmed by immunofluorescence staining. Treatment of cells with pharmacological inhibitors of PI3 kinase or ErbB1 blocked this effect. Thus, these results demonstrate the phosphorylation and nuclear exclusion of FKHR after EGF treatment by a PI3 kinase dependent mechanism, and represent the first report of growth factor regulation of endogenous FKHR localization

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 3
Figure 1
Figure 2
Figure 4
Figure 5

Similar content being viewed by others

References

  • Andjelkovic M, Allessi DR, Meier R, Fernandez A, Lamb NJ, Frech M, Cron P, Cohen P, Lucocq JM and Hemmings BA. . 1997 J. Biol. Chem. 272: 31515–31524.

  • Biggs III WH, Meisenhelder J, Hunter T, Cavenee WK and Arden KC. . 1999 Proc. Natl. Acad. Sci. USA 96: 7421–7426.

  • Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME. . 1999 Cell 96: 857–868.

  • Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R and Soltoff S. . 1991 Cell 64: 281–302.

  • Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S and Reed JC. . 1998 Science 282: 1318–1321.

  • Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y and Greenberg ME. . 1997 Cell 91: 231–241.

  • del Peso L, Gonzalez VM, Hernandez R, Barr FG and Nunez G. . 1999 Oncogene 18: 7328–7333.

  • Downward J. . 1998a Science 279: 673–674.

  • Downward J. . 1998b Curr. Opin. Cell Biol. 10: 262–267.

  • Durham SK, Suwanichkul A, Scheimann AO, Yee D, Jackson JG, Barr FG and Powell DR. . 1999 Endocrinology 140: 3140–3146.

  • Gale NW, Kaplan S, Lowenstein EJ, Schlessinger J and Bar-Sagi D. . 1993 Nature 363: 88–92.

  • Glass WFD and Kreisberg JI. . 1993 J. Cell Physiol. 157: 296–306.

  • Graus-Porta D, Beerli RR, Daly JM and Hynes NE. . 1997 EMBO J. 16: 1647–1655.

  • Guo S, Rena G, Cichy S, He X, Cohen P and Unterman T. . 1999 J. Biol. Chem. 274: 17184–17192.

  • Hackel PO, Zwick E, Prenzel N and Ullrich A. . 1999 Curr. Opin. Cell Biol. 11: 184–189.

  • Hu P, Margolis B, Skolnik EY, Lammers R, Ullrich A and Schlessinger J. . 1992 Mol. Cell Biol. 12: 981–990.

  • Jackson JG, White MF and Yee D. . 1998 J. Biol. Chem. 273: 9994–10003.

  • Jackson JG and Yee D. . 1999 Growth Horm. IGF Res. 9: 280–289.

  • Jackson JG, Yoneda T, Clark GM and Yee D. . 2000 Clin Cancer Res. 6: 1135–1139.

  • Kimura KD, Tissenbaum HA, Liu Y and Ruvkun G. . 1997 Science 277: 942–946.

  • Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL & Burgering BM. . 1999 Nature 398: 630–634.

  • Lewis GD, Lofgren JA, McMurtrey AE, Nuijens A, Fendly BM, Bauer KD and Sliwkowski MX. . 1996 Cancer Res. 56: 1457–1465.

  • Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, Bar-Sagi D, Margolis B and Schlessinger J. . 1993 Nature 363: 85–88.

  • Meier R, Alessi DR, Cron P, Andjelkovic M and Hemmings BA. . 1997 J. Biol. Chem. 272: 30491–30497.

  • Morris JZ, Tissenbaum HA and Ruvkun G. . 1996 Nature 382: 536–539.

  • Nakae J, Barr V and Accili D. . 2000 EMBO J. 19: 989–996.

  • Nakae J, Park BC and Accili D. . 1999 J. Biol. Chem. 274: 15982–15985.

  • Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA and Ruvkun G. . 1997 Nature 389: 994–999.

  • Paradis S and Ruvkun G. . 1998 Genes Dev. 12: 2488–2498.

  • Rena G, Guo S, Cichy SC, Unterman TG and Cohen P. . 1999 J. Biol. Chem. 274: 17179–17183.

  • Salomon DS, Brandt R, Ciardiello F and Normanno N. . 1995 Crit. Rev. Oncol. Hematol. 19: 183–232.

  • Soltoff SP and Cantley LC. . 1996 J. Biol. Chem. 271: 563–567.

  • Soltoff SP, Carraway III KL, Prigent SA, Gullick WG and Cantley LC. . 1994 Mol. Cell Biol. 14: 3550–3558.

  • Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, Gaffney PR, Reese CB, McCormick F, Tempst P, Coadwell J and Hawkins PT. . 1998 Science 279: 710–714.

  • Takaishi H, Konishi H, Matsuzaki H, Ono Y, Shirai Y, Saito N, Kitamura T, Ogawa W, Kasuga M, Kikkawa U and Nishizuka Y. . 1999 Proc. Natl. Acad. Sci. USA 96: 11836–11841.

  • Tang ED, Nunez G, Barr FG and Guan KL. . 1999 J. Biol. Chem. 274: 16741–16746.

  • Thomas D and Bradshaw RA. . 1997 J. Biol. Chem. 272: 22293–22299.

  • Vijapurkar U, Cheng K and Koland JG. . 1998 J. Biol. Chem. 273: 20996–21002.

  • Wymann MP and Pirola L. . 1998 Biochim. Biophys. Acta 1436: 127–150.

Download references

Acknowledgements

The authors wish to thank Delfino R Garza for technical help with FKHR immunoblotting. This work was supported by grants CA54807, CA34432 (MG Brattain) and CA74285, CA54174 (D Yee); JI Kreisberg is supported by a merit review and Career Scientist Award from the Department of Veterans Affairs.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jackson, J., Kreisberg, J., Koterba, A. et al. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells. Oncogene 19, 4574–4581 (2000). https://doi.org/10.1038/sj.onc.1203825

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203825

Keywords

This article is cited by

Search

Quick links